Nonspanning bivalent ligands as improved surface receptor binding inhibitors of the cholera toxin B pentamer

Chemistry & Biology
Jason C PickensErkang Fan

Abstract

A series of bivalent ligands of varying length were synthesized to inhibit the receptor-binding process of cholera toxin. Competitive surface receptor binding assays showed that significant potency gains relative to the constituent monovalent ligands were achieved independently from the ability of the extended bivalent ligands to span binding sites within the toxin pentamer. Several models that could account for the unexpected improvement in IC(50) values are examined, taking into account crystallographic analysis of each ligand in complex with the toxin pentamer. Evidence is presented that steric blocking at the receptor binding surface may play a role. The results of our study suggest that the use of relatively short, "nonspanning" bivalent ligands, or monovalent ligands of similar topology and bulk may be an effective way of blocking the interaction of multimeric proteins with their cell surface receptors.

References

Apr 1, 1995·Current Opinion in Structural Biology·E A Merritt, W G Hol
May 23, 1996·Nature·R W HooftE E Abola
Mar 25, 1999·Acta Crystallographica. Section D, Biological Crystallography·A A VaguineS J Wodak
May 20, 1999·Nature Structural Biology·A PerrakisV S Lamzin
Dec 15, 2000·Current Opinion in Structural Biology·E FanW G Hol
Dec 26, 2001·Journal of the American Chemical Society·J M GarganoW J Lees
Oct 31, 2002·Journal of the American Chemical Society·Zhongsheng ZhangErkang Fan
Mar 13, 2003·Journal of the American Chemical Society·Pavel I KitovDavid R Bundle
Dec 25, 2003·Journal of the American Chemical Society·Pavel I Kitov, David R Bundle
May 1, 1997·Acta Crystallographica. Section D, Biological Crystallography·G N MurshudovE J Dodson
Jan 1, 1997·Methods in Enzymology·E A Merritt, D J Bacon
Jan 1, 1997·Methods in Enzymology·Zbyszek Otwinowski, Wladek Minor

❮ Previous
Next ❯

Citations

Oct 18, 2011·Digestive Diseases and Sciences·Michael CamilleriTyler Nelsen
Apr 6, 2005·Trends in Pharmacological Sciences·Jay R Thiagarajah, A S Verkman
May 9, 2013·Future Medicinal Chemistry·Chatchai Muanprasat, Varanuj Chatsudthipong
Nov 25, 2005·Journal of the American Chemical Society·Ying Wang, Kristi L Kiick
Nov 23, 2013·Proteins·Tim Meyer, Ernst-Walter Knapp
Jan 28, 2014·Current Opinion in Chemical Biology·Valentin Wittmann
Jun 28, 2016·Journal of Medicinal Chemistry·Domenique D Zomer-van OmmenRoland J Pieters
Mar 24, 2012·Angewandte Chemie·Mattias E IvarssonBastien Castagner
Nov 27, 2008·Chembiochem : a European Journal of Chemical Biology·Cristina SisuW Bruce Turnbull
Apr 20, 2019·Medicinal Research Reviews·Xiangyi JiangPeng Zhan
Nov 23, 2007·The Journal of Pharmacology and Experimental Therapeutics·Prapapimon PariwatVaranuj Chatsudthipong
Dec 1, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·N D SonawaneA S Verkman
Jul 11, 2012·ChemMedChem·Priam VillalongaAntoni Costa
Nov 4, 2011·Organic & Biomolecular Chemistry·David J LeaverAndrew B Hughes
Mar 10, 2018·Beilstein Journal of Organic Chemistry·Vajinder Kumar, W Bruce Turnbull
Aug 28, 2019·Chemistry : a European Journal·Antonio BauzáTiddo Jonathan Mooibroek
Jun 6, 2013·Organic & Biomolecular Chemistry·Martin MattarellaJay S Siegel
Jul 23, 2013·Chemical Society Reviews·Frederik R Wurm, Harm-Anton Klok
Jun 10, 2010·Journal of the American Chemical Society·David SchwefelValentin Wittmann
Feb 14, 2009·Macromolecules·Shuang Liu, Kristi L Kiick

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.